| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $326.5M | -15.0% |
| Cost of Revenue | $226.9M | -3.4% |
| Gross Profit | $99.6M | -33.1% |
| R&D Expense | $3.6M | +111.8% |
| SG&A Expense | $105.5M | +7.3% |
| Operating Income | -$42.5M | -448.4% |
| Interest Expense | $20.7M | -7.6% |
| Pre-tax Income | -$56.7M | -1057.1% |
| Income Tax | -$15.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62.8M | -39.6% |
| Accounts Receivable | $33.0M | -24.5% |
| Inventory | $25.0M | -24.0% |
| Current Assets | $139.6M | -27.1% |
| Total Assets | $1.13B | -6.6% |
| Current Liabilities | $39.1M | -45.3% |
| Long-term Debt | $393.0M | -2.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.1M | -98.0% |
| Capital Expenditures | $44.8M | -17.8% |
| Investing Cash Flow | -$37.9M | +45.7% |
| Financing Cash Flow | -$4.5M | -106.3% |
| Free Cash Flow | -$43.7M | — |
| -628.6% |
| Net Income | -$41.4M | -1378.6% |
| EPS (Basic) | -$0.51 | -1175.0% |
| EPS (Diluted) | -$0.51 | -1175.0% |
| Total Liabilities |
| $520.7M |
| -9.8% |
| Stockholders' Equity | $612.8M | -3.7% |